TB-500: the Thymosin Beta-4 analogue TB-500 is a synthetic analogue or fragment of Thymosin Beta-4, a 43-amino-acid actin-sequestering protein involved in cell migration, angiogenesis, and wound healing [5]
Current Evidence for Efficacy Preclinical Studies The majority of evidence supporting the therapeutic efficacy of BPC-157 and TB-500 derives from extensive preclinical investigations conducted in various experimental models
After he published a series of animal and cell studies on humanins potential benefitsthe peptide seemed to curb inflammation, control glucose, and possibly even provide protection against Alzheimersso-called biohackers began ordering it on the gray market
The results are stunning
Finally, the review notes that a couple of clinical studies on TB4 for wound healing both resulted in the peptide accelerating the healing process.21 March 2024 study Interestingly, in a 2024 study, researchers found that TB-500 (Ac-LKKTETQ) didnt increase wound-healing activity, but one of its metabolites Ac-LKKTE did
It covers everything from equipment to concentration calculations, includes a full reference table for common vial sizes, explains the reasoning behind each step, and addresses the problems researchers actually encounter
